SCHEMBL4760788

SCHEMBL4760788

CC(=O)NCC(C)(C)CS(=O)(=O)[O-].CC(=O)NCC(C)(C)CS(=O)(=O)[O-].[Ca+2]

nearest known ligand 0.33

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.33
GRK2 P25098 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
APAF1 O14727 1/20 0.33
DNMT1 P26358 1/20 0.33
PTPN7 P35236 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
PPP1CA P62136 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
PTPN22 Q9Y2R2 1/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPK1 P28482 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7026914 0.80 KDM4E (0.38) SMN1; SMN2HSD17B10KDM4EMAPK1HIF1A
SCHEMBL4760790 0.78 KDM4E (0.37) SMN1; SMN2HSD17B10KDM4EMAPK1HIF1A
SCHEMBL13290414 0.77 KDM4E (0.40) L3MBTL1LMNASMN1; SMN2HSD17B10KDM4E
Lithium Ion SCHEMBL28457857 0.75 TSHR (0.39) POLBGRK2L3MBTL1APAF1DNMT1
SCHEMBL21915798 0.71 PAOX (0.38) L3MBTL1MEN1LMNAKMT2ASMN1; SMN2
SCHEMBL8436372 0.70 KDM4E (0.39) L3MBTL1LMNASMN1; SMN2HSD17B10KDM4E
SCHEMBL13290400 0.70 KDM4E (0.39) L3MBTL1SMN1; SMN2HSD17B10KDM4EMAPK1
SCHEMBL22826041 0.69 MMP8 (0.32) SMN1; SMN2HSD17B10KDM4EMAPK1HIF1A
SCHEMBL21452807 0.69 SMN1; SMN2 (0.41) L3MBTL1LMNASMN1; SMN2HSD17B10KDM4E
SCHEMBL21477756 0.69 KDM4E (0.37) L3MBTL1LMNASMN1; SMN2HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4156795-B2 2008-09-24 JP claimed
EP-1051393-B1 NEW DERIVATIVES OF SULFONIC, PHOSPHONIC AND PHOSPHINIC AMINOALKANE ACIDS, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS MERCK SANTE SAS (FR) 2003-10-01 EP claimed
JP-2002501040-A 2002-01-15 JP claimed
US-6265437-B1 ALCOHOLISM LIPHA (FR) 2001-07-24 US claimed
EP-1051393-A1 NEW DERIVATIVES OF SULFONIC, PHOSPHONIC AND PHOSPHINIC AMINOALKANE ACIDS, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS LIPHA (FR) 2000-11-15 EP claimed
WO-1999037606-A1 NEW DERIVATIVES OF SULFONIC, PHOSPHONIC AND PHOSPHINIC AMINOALKANE ACIDS, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS LIPHA (FR) 1999-07-29 WO claimed
US-6265437-B1 ALCOHOLISM LIPHA (FR) 2001-07-24 US disclosed